amobarbital has been researched along with Deaf Mutism in 2 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wolff, AB | 1 |
| Sass, KJ | 1 |
| Keidan, J | 1 |
| Marriage, K | 1 |
| Govorchin, M | 1 |
| George, P | 1 |
| Dilworth, C | 1 |
2 other studies available for amobarbital and Deaf Mutism
| Article | Year |
|---|---|
Case report of an intracarotid amobarbital procedure performed for a deaf patient.
Topics: Adult; Amobarbital; Carotid Artery, Internal; Communication Methods, Total; Deafness; Dominance, Cer | 1994 |
Use of an amytal interview in the management of factitious deaf mutism.
Topics: Adult; Amobarbital; Deafness; Factitious Disorders; Female; Humans; Munchausen Syndrome; Referral an | 1988 |